Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03975413 · ClinicalTrials.gov registry record
Fecal Microbiota Transplantation (FMT) in Multiple Sclerosis
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 1
- Enrollment target
NCT03975413 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 1 participants.
The verdict
NCT03975413 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
Multiple sclerosis (MS) is a chronic immune central nervous system (CNS) disease of unknown cause. Recent studies suggest that gut microbiota could be a trigger for the neuro-inflammation in MS and abnormal gut microbiota composition has been reported in MS patients. These data provided scientific rationale for microbiota-directed intervention, like stool transplant, for the treatment of MS.
Interventions
- OTHER Fecal Microbiota Transplantation (FMT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-09-25 |
| Est. Completion | 2020-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03975413
The ClinicalTrials.gov registry entry for NCT03975413 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fecal Microbiota Transplantation (FMT) is the first listed.
NCT03975413 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03975413 about?
NCT03975413 is a clinical study titled "Fecal Microbiota Transplantation (FMT) in Multiple Sclerosis". Multiple sclerosis (MS) is a chronic immune central nervous system (CNS) disease of unknown cause. Recent studies suggest that gut microbiota could be a trigger for the neuro-inflammation in MS and abnormal gut microbiota composition has been reported in MS patients. These data provided scientific r...
What is the current status of trial NCT03975413?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2018-09-25. Estimated completion is 2020-05-01.
What interventions are being tested in trial NCT03975413?
The interventions under investigation include: Fecal Microbiota Transplantation (FMT) (OTHER).
Who is sponsoring clinical trial NCT03975413?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.